-
1
-
-
0027569787
-
Angiotensin- Converting Enzyme Inhibitor Fetopathy
-
PRYDE PG, SEDMAN AB, NUGENT CE, BARR MJ: Angiotensin- Converting Enzyme Inhibitor Fetopathy J Am Soc Nephro 1993;3(9):1575-82
-
(1993)
J Am Soc Nephro
, vol.3
, Issue.9
, pp. 1575-1582
-
-
Pryde, P.G.1
Sedman, A.B.2
Nugent, C.E.3
Barr, M.J.4
-
2
-
-
0028630616
-
Teratogen update: Angiotensin-converting enzyme inhibitors
-
BARR M JR: Teratogen update: Angiotensin-converting enzyme inhibitors Teratology 1994;50(6):399-409
-
(1994)
Teratology
, vol.50
, Issue.6
, pp. 399-409
-
-
Barr Jr., M.1
-
3
-
-
40849096262
-
Uptodate on the use of antihypertensive drugs in pregnancy
-
(acedido a 23 Abril de 2008)
-
PODYMOW T, AUGUST P: Uptodate on the use of antihypertensive drugs in pregnancy, Hypertension 2008;51:960-9 http://hyper.ahajournals.org/cgi/content/ full/51/4/960 (acedido a 23 Abril de 2008)
-
(2008)
Hypertension
, vol.51
, pp. 960-969
-
-
Podymow, T.1
August, P.2
-
4
-
-
0030729396
-
An overview of the influence of ACE inhibitors on fetalplacental circulation and perinatal development
-
BUTTAR HS: An overview of the influence of ACE inhibitors on fetalplacental circulation and perinatal development. Mol Cell Biochem 1997;176:61-71
-
(1997)
Mol Cell Biochem
, vol.176
, pp. 61-71
-
-
Buttar, H.S.1
-
5
-
-
31544445756
-
Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists
-
QUAN A: Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists. Early Hum Dev 2006;82(1):23-8
-
(2006)
Early Hum Dev
, vol.82
, Issue.1
, pp. 23-28
-
-
Quan, A.1
-
7
-
-
0348230631
-
Adverse pregnancy outcomes associated with maternal enalapril antihypertensive treatment
-
DOI 10.1002/pds.796
-
TABACOVA S, LITTLE R, TSONG Y, VEGA A, KIMMEL CA: Adverse pregnancy outcomes associated with maternal enalapril antihypertensive treatment. Pharmacoepid Drug Saf 2003; 12(8):633-646 (Pubitemid 38028777)
-
(2003)
Pharmacoepidemiology and Drug Safety
, vol.12
, Issue.8
, pp. 633-646
-
-
Tabacova, S.1
Little, R.2
Tsong, Y.3
Vega, A.4
Kimmel, C.A.5
-
8
-
-
4143104513
-
Development of AT1 and AT2 receptors to the ovine fetal brain
-
HU F, MORRISSEY P, YAO J, XU Z: Development of AT1 and AT2 receptors to the ovine fetal brain. Brain Res Dev 2004; 150:51-61
-
(2004)
Brain Res Dev
, vol.150
, pp. 51-61
-
-
Hu, F.1
Morrissey, P.2
Yao, J.3
Xu, Z.4
-
9
-
-
0035138671
-
Effects of gestation on ovine fetal and maternal angiotensin receptor subtypes in the heart and major blood vessels
-
BURRELL JH, HEGARTY BD, MCMULLEN JR, LUMBERS BR: Effects of gestation on ovine fetal and maternal angiotensin receptor subtypes in the heart and major blood vessels. Exp Physiol 2001;86:71-82
-
(2001)
Exp Physiol
, vol.86
, pp. 71-82
-
-
Burrell, J.H.1
Hegarty, B.D.2
Mcmullen, J.R.3
Lumbers, B.R.4
-
10
-
-
33744966030
-
Major Congenital Malformations after First-Trimester exposure to ACE Inibitors
-
COOPER WO et al: Major Congenital Malformations after First-Trimester exposure to ACE Inibitors. N Engl J Med 2006;354(23):2443-51
-
(2006)
N Engl J Med
, vol.354
, Issue.23
, pp. 2443-2451
-
-
Cooper, W.O.1
-
11
-
-
37549002508
-
Clinical implications of increased congenital malformations after first trimester exposures to angiotensin-converting enzyme inhibitors
-
COOPER WO: Clinical implications of increased congenital malformations after first trimester exposures to angiotensin-converting enzyme inhibitors. J Cardiovasc Nurs 2008;23(1):20-4
-
(2008)
J Cardiovasc Nurs
, vol.23
, Issue.1
, pp. 20-24
-
-
Cooper, W.O.1
|